患有和未患肾炎的系统性红斑狼疮患者给雇主带来的直接和间接成本。
Direct and indirect costs to employers of patients with systemic lupus erythematosus with and without nephritis.
作者信息
Carls Ginger, Li Tracy, Panopalis Pantelis, Wang Shaohung, Mell Amy G, Gibson Teresa B, Goetzel Ron Z
机构信息
Health and Productivity Division, Thomson Healthcare, Ann Arbor, Mich, USA.
出版信息
J Occup Environ Med. 2009 Jan;51(1):66-79. doi: 10.1097/JOM.0b013e31818a405a.
OBJECTIVES
To estimate the medical- and productivity-related cost burden of systemic lupus erythematosus (SLE) and SLE with nephritis in an employee population.
METHODS
Using administrative data, annual costs were calculated for SLE patients, a subset with nephritis, and a matched control group of patients without SLE. These costs were compared with the cost of other chronic conditions.
RESULTS
Mean annual medical expenditures and short term disability costs for SLE patients were $12,238 and $1184 greater (2005 dollars), respectively, than those of controls. Mean medical expenditures for SLE/nephritis patients were $46,862 greater than for controls. When compared with other chronic health conditions faced by employees, SLE/nephritis was the most costly condition.
CONCLUSIONS
SLE, particularly with nephritis, is associated with substantial costs. Therapies that can better manage SLE may provide opportunities for savings to employers.
目的
评估员工群体中系统性红斑狼疮（SLE）及狼疮性肾炎的医疗和生产力相关成本负担。
方法
利用行政数据，计算SLE患者、患有肾炎的亚组患者以及匹配的无SLE对照组患者的年度成本。将这些成本与其他慢性病的成本进行比较。
结果
SLE患者的年均医疗支出和短期残疾成本（以2005年美元计）分别比对照组高12,238美元和1184美元。SLE/肾炎患者的平均医疗支出比对照组高46,862美元。与员工面临的其他慢性健康状况相比，SLE/肾炎是成本最高的状况。
结论
SLE，尤其是伴有肾炎的情况，会带来巨大成本。能够更好地管理SLE的疗法可能为雇主提供节省成本的机会。
Zotero 插件